Artificial intelligence (AI) is expanding clinical trial access and enabling drug repurposing, according to Vivek Subbiah, MD.
Ten health systems are teaming up to explore strategy, ethics, governance and scaling of agentic AI at their organizations. The first cohort of the collaborative, organized by digital transformation ...
DPA International on MSN
EU Commission unveils 'AI first' strategy to boost competitiveness
The European Commission is set to allocate approximately €1 billion ($1.16 billion) on the increased use of artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback